Join us for 60 minute webinar from the safety of your home or office.
At the end of this unaccredited session participants will:
- Identify early breast cancers that benefit from genomic profiling to guide adjuvant
therapy.
- Understand recent trial evidence supporting de-escalation of adjuvant treatment.
- Identify limitations of current genomic profiling tools.
This session will be a review of landmark prospective early stage breast cancer randomized trials guiding the selection and application of genomic profiling of early stage breast cancers.
Presented by:
